Oral Vaccination Against Clostridium Difficile Infection

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

NCT04026009 ·Status: COMPLETED ·Phase: PHASE1

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

NCT03918629 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

NCT00214461 ·Status: COMPLETED ·Phase: PHASE1

Clostridium Difficile Vaccine Efficacy Trial

NCT03090191 ·Status: COMPLETED ·Phase: PHASE3

Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity

NCT00772954 ·Status: TERMINATED ·Phase: PHASE1

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

NCT07282665 ·Status: RECRUITING ·Phase: PHASE3

Phase I Trial of a Single Dose of CRS3123

NCT01551004 ·Status: COMPLETED ·Phase: PHASE1

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

NCT03579459 ·Status: COMPLETED ·Phase: PHASE3

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

NCT01230957 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years

NCT01706367 ·Status: COMPLETED ·Phase: PHASE1

Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

NCT02725437 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84

NCT01296386 ·Status: COMPLETED ·Phase: PHASE1

LMN-201 for Prevention of C. Difficile Infection Recurrence

NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Screening to Prophylax Against Clostridium Difficile Infection -

NCT02996487 ·Status: COMPLETED ·Phase: PHASE4

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

NCT01887912 ·Status: TERMINATED ·Phase: PHASE3

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

NCT00772343 ·Status: COMPLETED ·Phase: PHASE2

Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics

NCT02951702 ·Status: COMPLETED ·Phase: PHASE4

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

NCT01896830 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

NCT03988855 ·Status: UNKNOWN ·Phase: PHASE2

Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study

NCT02316470 ·Status: COMPLETED ·Phase: PHASE2

Freeze-dried, Capsulized FMT for RCDI

NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

NCT01232595 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

NCT01716533 ·Status: COMPLETED ·Phase: NA

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

NCT03110133 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

NCT01259726 ·Status: COMPLETED ·Phase: PHASE2